ZA200403614B - Controlled release tablets of metformin. - Google Patents
Controlled release tablets of metformin.Info
- Publication number
- ZA200403614B ZA200403614B ZA200403614A ZA200403614A ZA200403614B ZA 200403614 B ZA200403614 B ZA 200403614B ZA 200403614 A ZA200403614 A ZA 200403614A ZA 200403614 A ZA200403614 A ZA 200403614A ZA 200403614 B ZA200403614 B ZA 200403614B
- Authority
- ZA
- South Africa
- Prior art keywords
- metformin
- controlled release
- release tablets
- tablets
- controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1134DE2001 | 2001-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200403614B true ZA200403614B (en) | 2005-01-14 |
Family
ID=11097132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200403614A ZA200403614B (en) | 2001-11-06 | 2004-05-12 | Controlled release tablets of metformin. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20030104059A1 (xx) |
EP (1) | EP1465612A1 (xx) |
KR (1) | KR20050043765A (xx) |
CN (1) | CN1700910A (xx) |
EA (1) | EA200400628A1 (xx) |
HU (1) | HUP0402058A3 (xx) |
PL (1) | PL369328A1 (xx) |
WO (1) | WO2003039527A1 (xx) |
ZA (1) | ZA200403614B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1515701B1 (en) * | 2002-06-17 | 2014-09-17 | Inventia Healthcare Private Limited | Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide |
WO2004110422A1 (en) * | 2003-06-16 | 2004-12-23 | Ranbaxy Laboratories Limited | Extended-release tablets of metformin |
WO2005092293A1 (en) * | 2004-03-22 | 2005-10-06 | Ranbaxy Laboratories Limited | Formulations of metformin |
US20060088594A1 (en) * | 2004-10-08 | 2006-04-27 | Pilgaonkar Pratibha S | Highly compressible controlled delivery compositions of metformin |
AU2010319438B2 (en) * | 2009-11-13 | 2015-05-21 | Astrazeneca Uk Limited | Reduced mass metformin formulations |
US11974971B2 (en) | 2011-01-07 | 2024-05-07 | Anji Pharmaceuticals Inc. | Compositions and methods for treating metabolic disorders |
WO2013103384A1 (en) | 2012-01-06 | 2013-07-11 | Elcelyx Therapeutics, Inc. | Biguanide compositions and methods of treating metabolic disorders |
US11759441B2 (en) | 2011-01-07 | 2023-09-19 | Anji Pharmaceuticals Inc. | Biguanide compositions and methods of treating metabolic disorders |
US8796338B2 (en) | 2011-01-07 | 2014-08-05 | Elcelyx Therapeutics, Inc | Biguanide compositions and methods of treating metabolic disorders |
US9480663B2 (en) | 2011-01-07 | 2016-11-01 | Elcelyx Therapeutics, Inc. | Biguanide compositions and methods of treating metabolic disorders |
US9211263B2 (en) | 2012-01-06 | 2015-12-15 | Elcelyx Therapeutics, Inc. | Compositions and methods of treating metabolic disorders |
HUE051738T2 (hu) | 2011-01-07 | 2021-03-29 | Anji Pharma Us Llc | Kemoszenzoros receptorligandum-alapú terápiák |
US9572784B2 (en) | 2011-01-07 | 2017-02-21 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
BR112014016810A8 (pt) | 2012-01-06 | 2017-07-04 | Elcelyx Therapeutics Inc | composições e métodos para tratamento de distúrbios metabólicos |
WO2016042567A1 (en) * | 2014-09-16 | 2016-03-24 | Suresh Pareek | Extended release formulation of metformin |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4432757A1 (de) * | 1994-09-14 | 1996-03-21 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung |
ES2248908T7 (es) * | 1997-06-06 | 2014-11-24 | Depomed, Inc. | Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles |
AU736951C (en) * | 1998-03-19 | 2003-02-20 | Bristol-Myers Squibb Company | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
US6117451A (en) * | 1998-08-25 | 2000-09-12 | Pharmalogix, Inc. | Direct compression metformin hydrochloride tablets |
DK1140027T3 (da) * | 1998-12-23 | 2006-02-27 | Alza Corp | Doseringsformer indeholdende poröse partikler |
ES2392705T3 (es) * | 2000-10-02 | 2012-12-13 | Usv Ltd. | Composiciones farmacéuticas de liberación sostenida que contienen metformina y método para su producción |
-
2002
- 2002-11-06 KR KR1020047006875A patent/KR20050043765A/ko not_active Application Discontinuation
- 2002-11-06 PL PL02369328A patent/PL369328A1/xx not_active Application Discontinuation
- 2002-11-06 WO PCT/IB2002/004647 patent/WO2003039527A1/en not_active Application Discontinuation
- 2002-11-06 US US10/289,070 patent/US20030104059A1/en not_active Abandoned
- 2002-11-06 EA EA200400628A patent/EA200400628A1/ru unknown
- 2002-11-06 CN CNA028264266A patent/CN1700910A/zh active Pending
- 2002-11-06 EP EP02802686A patent/EP1465612A1/en not_active Withdrawn
- 2002-11-06 HU HU0402058A patent/HUP0402058A3/hu unknown
-
2004
- 2004-05-12 ZA ZA200403614A patent/ZA200403614B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1465612A1 (en) | 2004-10-13 |
HUP0402058A3 (en) | 2006-04-28 |
PL369328A1 (en) | 2005-04-18 |
CN1700910A (zh) | 2005-11-23 |
EA200400628A1 (ru) | 2004-12-30 |
HUP0402058A2 (hu) | 2005-02-28 |
KR20050043765A (ko) | 2005-05-11 |
WO2003039527A1 (en) | 2003-05-15 |
US20030104059A1 (en) | 2003-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL161525A0 (en) | Modified release tamsulosin tablets | |
AU2002327068A1 (en) | Immediate release tablet | |
AU2002301845A1 (en) | Modified release tamsulosin tablets | |
TWI347202B (en) | Controlled release preparation | |
ZA200204020B (en) | Use of anti-CTLA-4-antibodies. | |
EP1581160A4 (en) | ENCAPSULATION PRODUCTS PROVIDING CONTROLLED OR PROLONGED DELIVERY | |
MXPA03009229A (es) | Microcapsulas. | |
ZA200409617B (en) | Microcapsule formulations. | |
AU2002363360A1 (en) | Dual controlled release dosage form | |
HK1051639A1 (en) | Buckle. | |
HUP0500004A3 (en) | Extended release pharmaceutical tablet of metformin | |
EP1372614A4 (en) | SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE | |
ZA200403614B (en) | Controlled release tablets of metformin. | |
IL163887A0 (en) | Controlled release dosage forms | |
EP1335708A4 (en) | METFORMIN COMPOSITIONS WITH CONTROLLED RELEASE | |
IL162019A0 (en) | Mousse | |
GB0124338D0 (en) | Biochips | |
EP1457204A4 (en) | SHAPED PRODUCT OF RELEASE CONTROL TYPE | |
GB0115761D0 (en) | Capsules | |
AU2002363392A1 (en) | Controlled release tablets of metformin | |
HK1050120A1 (en) | Watchband. | |
GB2375521B (en) | Davits | |
ZA200305944B (en) | Novel modified release formulation. | |
ZA200104935B (en) | Extended release buccal tablet. | |
AU2002343227A1 (en) | Modified release tamsulosin tablets |